64 reports

It excludes all other OTC products and those which require prescriptions but includes pharmacy approved.

  • OTC
  • Austria
  • Canada
  • GlaxoSmithKline plc
  • Nielsen Co.

It excludes all other OTC products and those which require prescriptions but includes pharmacy approved.

  • OTC
  • Austria
  • Canada
  • GlaxoSmithKline plc
  • Kwizda Pharma GmbH
  • DEFINITIONS
  • Passport 11

One of the proposed regulatory amendments that Health Canada plans to implement during the early part of the forecast period is to ban the OTC sale of products containing codeine.

  • OTC
  • Canada
  • Demand
  • Parents Remain Cautious Around Giving OTC Products To Their Children
  • Passport 17

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • OTC
  • Austria
  • Demand
  • Austrians Remain Cautious When Purchasing OTC Dermatologicals for Their Children
  • Passport 17

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • Acne Treatment
  • OTC
  • Austria
  • Demand
  • Passport 15
  • SOURCES

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • OTC
  • Wound Care
  • Austria
  • Demand
  • Passport 15
  • SOURCES

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • OTC
  • Sleep Aid
  • Austria
  • Demand
  • Forecast
  • DEFINITIONS
  • Passport 8

One of the proposed regulatory amendments that Health Canada plans to implement during the early part of the forecast period is to ban the OTC sale of products containing codeine.

  • OTC
  • Canada
  • Demand
  • Pharmacy Industry Consolidates While OTC E-commerce Remains Largely Untapped
  • DEFINITIONS

One of the proposed regulatory amendments that Health Canada plans to implement during the early part of the forecast period is to ban the OTC sale of products containing codeine.

  • Ophthalmic Solution
  • OTC
  • Canada
  • Demand
  • SOURCES
  • PAEDIATRIC CONSUMER HEALTH IN AUSTRIA - CATEGORY ANALYSIS

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • OTC
  • Austria
  • Demand
  • Forecast
  • GlaxoSmithKline plc

For this report, CAGR for historic time period is Calculated from 2012-2017, as CAGR = ((2017 Value / 2012 Value) ^ (## / (2017-2012))) - ## CAGR for forecast time period is Calculated from 2017-2022, as CAGR = ((2022 Value / 2017 Value) ^ (## / (2022-2017

  • Hair Growth
  • OTC
  • Canada
  • Market Size
  • Johnson & Johnson Services Inc
  • DEFINITIONS
  • EXECUTIVE SUMMARY

One of the proposed regulatory amendments that Health Canada plans to implement during the early part of the forecast period is to ban the OTC sale of products containing codeine.

  • OTC
  • Canada
  • Demand
  • Bayer AG
  • GlaxoSmithKline plc
  • GLAXOSMITHKLINE PLC: KEY FACTS

Under the Consumer Healthcare segment, GSK specializes in OTC and consumer healthcare care products.

  • Oral Hygiene
  • OTC
  • Personal Hygiene
  • Canada
  • North America

Stores licensed to dispense prescription (Rx) and over-the-counter (OTC) healthcare products and where these sales account for the majority of revenues.

  • OTC
  • Austria
  • Canada
  • Coty Inc.
  • Estee Lauder Companies Inc.

Stores licensed to dispense prescription (Rx) and over-the-counter (OTC) healthcare products and where these sales account for the majority of revenues.

  • Hair Care
  • OTC
  • Canada
  • Market Segment
  • L'Oreal S.A.
  • CANADA OTC PHARMACEUTICALS MARKET CATEGORY SEGMENTATION: $ MILLION, 2015
  • FACTORS INFLUENCING THE THREAT OF SUBSTITUTES IN THE OTC PHARMACEUTICALS MARKET IN CANADA, 2015

It has three R& D centers (two in Germany and one in Spain).

  • OTC
  • Austria
  • Canada
  • Market Size
  • Almirall, S.A.
  • Passport 18
  • SOURCES

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • Analgesic
  • OTC
  • Austria
  • Demand
  • Passport 15
  • SOURCES

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • OTC
  • Weight Loss
  • Austria
  • Demand
  • Passport 15
  • SOURCES

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • Ophthalmic Solution
  • OTC
  • Austria
  • Demand
  • Passport 18
  • SOURCES

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • Allergy Drug
  • OTC
  • Austria
  • Demand
  • Passport 17
  • SOURCES

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • OTC
  • Austria
  • Demand
  • Passport 17
  • SOURCES

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • Gastrointestinal Drug
  • OTC
  • Austria
  • Demand
  • Passport 16
  • SOURCES

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • Functional Food
  • OTC
  • Sport Nutritional
  • Austria
  • Demand
  • Passport 16
  • SOURCES

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • Dietary Supplement
  • OTC
  • Vitamin
  • Austria
  • Demand
  • Passport 18
  • SOURCES

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • Dietary Supplement
  • OTC
  • Austria
  • Demand
  • Passport 15
  • SOURCES

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • OTC
  • Smoking Cessation
  • Austria
  • Demand
  • Pharmacy Industry Consolidates While OTC E-commerce Remains Largely Untapped
  • DEFINITIONS

One of the proposed regulatory amendments that Health Canada plans to implement during the early part of the forecast period is to ban the OTC sale of products containing codeine.

  • OTC
  • Canada
  • Demand
  • DEFINITIONS
  • Passport 7

One of the proposed regulatory amendments that Health Canada plans to implement during the early part of the forecast period is to ban the OTC sale of products containing codeine.

  • OTC
  • Canada
  • Demand
  • DEFINITIONS
  • Passport 11

One of the proposed regulatory amendments that Health Canada plans to implement during the early part of the forecast period is to ban the OTC sale of products containing codeine.

  • OTC
  • Canada
  • Demand
  • DEFINITIONS
  • Passport 12

One of the proposed regulatory amendments that Health Canada plans to implement during the early part of the forecast period is to ban the OTC sale of products containing codeine.

  • Dietary Supplement
  • OTC
  • Canada
  • Demand